Tocilizumab and anti-tumour necrosis factor as first biologic agents in patients with rheumatoid arthritis. Efficacy data from the Rheumatic Diseases Portuguese Register.
Phase of Trial: Phase IV
Latest Information Update: 02 Sep 2015
At a glance
- Drugs Anti-TNF monoclonal antibodies (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 02 Sep 2015 New trial record